Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

In vivo Analysis of Glial Cell Phenotypes during a Viral Demyelinating Disease in Mice

Catherine Godfraind, Victor L. Friedrich, Kathryn V. Holmes and Monique Dubois-Dalcq
The Journal of Cell Biology
Vol. 109, No. 5 (Nov., 1989), pp. 2405-2416
Stable URL: http://www.jstor.org/stable/1613738
Page Count: 12
  • More info
  • Cite this Item
In vivo Analysis of Glial Cell Phenotypes during a Viral Demyelinating Disease in Mice
Preview not available

Abstract

C57 BL/6N mice injected intracranially with the A59 strain of mouse hepatitis virus exhibit extensive viral replication in glial cells of the spinal cord and develop demyelinating lesions followed by virus clearing and remyelination. To study how different glial cell types are affected by the disease process, we combine three-color immunofluorescence labeling with tritiated thymidine autoradiography on 1-μm frozen sections of spinal cord. We use three different glial cell specific antibodies (a) to 2′, 3′ cyclic-nucleotide 3′ phosphohydrolase (CNP) expressed by oligodendrocytes, (b) to glial fibrillary acidic protein (GFAP) expressed by astrocytes, and (c) the O4 antibody which binds to O-2A progenitor cells in the rat. These progenitor cells, which give rise to oligodendrocytes and type 2 astrocytes and react with the O4 antibody in the adult central nervous system, were present but rare in the spinal cord of uninfected mice. In contrast, cells with the O-2A progenitor phenotype (O4+ only) were increased in number at one week post viral inoculation (1 WPI) and were the only immunostained cells labeled at that time by a 2-h in vivo pulse of tritiated thymidine. Both GFAP+ only and GFAP+, O4+ astrocytes were also increased in the spinal cord at 1 WPI. Between two and four WPI, the infected spinal cord was characterized by the loss of (CNP+, O4+) oligodendrocytes within demyelinating lesions and the presence of O-2A progenitor cells and O4+, GFAP+ astrocytes, both of which could be labeled with thymidine. As remyelination proceeded, CNP immunostaining returned to near normal and tritiated thymidine injected previously during the demyelinating phase now appeared in CNP+ oligodendrocytes. Thus O4 positive O-2A progenitor cells proliferate early in the course of the demyelinating disease, while CNP positive oligodendrocytes do not. The timing of events suggests that the O-2A progenitors may give rise to new oligodendrocytes and to type 2 astrocytes, both of which are likely to be instrumental in the remyelination process.

Page Thumbnails

  • Thumbnail: Page 
2405
    2405
  • Thumbnail: Page 
2406
    2406
  • Thumbnail: Page 
2407
    2407
  • Thumbnail: Page 
2408
    2408
  • Thumbnail: Page 
2409
    2409
  • Thumbnail: Page 
2410
    2410
  • Thumbnail: Page 
2411
    2411
  • Thumbnail: Page 
2412
    2412
  • Thumbnail: Page 
2413
    2413
  • Thumbnail: Page 
2414
    2414
  • Thumbnail: Page 
2415
    2415
  • Thumbnail: Page 
2416
    2416